When President Trump began his second term in office, he promptly signed an executive order to withdraw the USA from the United Nation’s Paris Agreement for a second time, it has now become even more important to consider how, as individuals and businesses, we can act sustainably. Practice Plan Area Manager, Katrina Rees, spoke to Mark Topley (pictured) to get his thoughts.
Dentisan’s parent company Quadralene, has been recognised for their recent significant increase in international sales, winning the Medilink East Midlands Export Achievement Award.
The increase has been driven largely by Quadralene’s expansion in healthcare markets and their products are now sold in 41 countries worldwide. In 2012, overseas sales increased by 70% and are forecast to rise by a further 50% this year.
Managing Director of Dentisan, Andy Corley, said, “I am thrilled to receive this award on behalf of a terrific team that works hard each day to build our growing reputation as a leader in the field of infection control. Their tireless effort on behalf of our international clients is what makes the difference. This award is proof that their work is recognised not only in the UK market but also on a global stage.”
Medilink is an organisation that celebrates the latest technologies, outstanding business achievement and international success across the UK Life Sciences sector and this is not the first Medilink award-win for the company. Two years ago, Dentisan received an “Outstanding Achievement” award for their collaborative work with University of Nottingham School of Biosciences in developing Bioclear, a biofilm remover for Dental Unit Water Lines. The company now goes forward to Medilink’s National Finals, held at the end of the year.
For more details of Dentisan’s full range of infection control products visit www.dentisan.co.uk
Dentisan Ltd on Facebook
@DentisanLtd on Twitter
GDPUK Ltd today announces the sale of its intellectual property assets to Cogora Group, one of the UK's leading publishers of healthcare brands and educational platforms.
The decision to sell GDPUK’s intellectual property forms part of a considered transition to ensure the long‑term stewardship and development of the brand and associated assets. Cogora brings a wealth of experience and expertise to support the continued evolution of the dentistry brand within its wide portfolio of market-leading healthcare publications. Its award-winning titles include Pulse, a long‑standing and widely recognised source of political news and clinical education for GPs, Nursing in Practice, Management in Practice, The Pharmacist, Pulse PCN and Healthcare Leader, as well as two secondary care publications – Hospital Healthcare Europe and Hospital Pharmacy Europe. The purchase will cement Cogora as the biggest publisher of primary care titles in the UK and allow it to bring its expertise in providing news, analysis, opinion and groundbreaking stories to GDPUK, as well as continue giving dentists and dental staff a voice through its website.
“After careful consideration, we believe that Cogora is well positioned to take GDPUK’s intellectual property forward,” said Tony Jacobs, founder, editor and publisher of GDPUK.com . “This transaction provides continuity for the professional community associated with GDPUK and creates opportunities for future growth under experienced ownership.”
GDPUK Ltd has worked to ensure an orderly transfer of the intellectual property and wishes Cogora every success in its future development.
